Category: Pharma Industry

J&J Offers Refunds on Blockbuster Drug, Other Manufacturers Update NDCs

January 3, 2024 Rich Daly, Editor in Chief Views

Johnson & Johnson has ended its contract pharmacy restrictions for Arkansas covered entities.

Drugmaker Johnson & Johnson will offer refunds to 340B providers related to the purchases of four of its drugs, including [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

2023 Contract Pharmacy Developments: Surging Restrictions, State Law Legal Battles

January 3, 2024 William Newton, Associate Editor/Senior Writer Views

In 2023, Arkansas became the first state to move to enforce a 340B contract pharmacy law as manufacturer restrictions continued to increase.

In 2023, the battle over the use of contract pharmacy arrangements by 340B providers was marked by increasing drugmaker restrictions, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Louisiana, Health Centers Seek Dismissal of Contract Pharmacy Law Challenge

December 21, 2023 William Newton, Associate Editor/Senior Writer Views

AstraZeneca will discontinue a certain bottle dosage of its breast cancer drug Truqap (capiversatib) by the end of the year but allow 340B covered entities to replenish their supply with an equivalent dose in blister pack package form.

Attorneys representing the state of Louisiana and 340B providers urged a federal judge to dismiss AstraZeneca’s lawsuit against Louisiana’s contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Lilly to Conduct HRSA-Approved Audit That Includes First-Time Look for Medicaid MCO Duplicate Discounts

December 19, 2023 Rich Daly, Editor in Chief Views

Eli Lilly is conducting government approved 340B provider audits that for the first time look for certain Medicaid health plan duplicate discounts.

Federal regulators have approved a first-time 340B provider audit by a drug manufacturer to examine processes to prevent duplicate discounts [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Takeda Becomes 29th Drugmaker to Implement 340B Contract Pharmacy Restrictions

December 18, 2023 William Newton, Associate Editor/Senior Writer Views

Japanese drugmaker Takeda announced its cancer medication Ninlaro will be subject to its 340B contract pharmacy policy.

Japanese pharmaceutical giant Takeda last Friday became the 29th drugmaker to place conditions on 340B pricing in the contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Novo Nordisk to Provide 340B Refunds on Hemophilia Drugs

December 14, 2023 Rich Daly, Editor in Chief Views

Novo Nordisk will issue 340B provider refunds for formulations of two hemophilia drugs, according to a HRSA manufacturer notice.

Novo Nordisk will issue its fifth round of refunds this year on prices charged to 340B providers. The latest are [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Legislation ‘Is Coming’ to Address Contract Pharmacy Restrictions, Hospital Advocate Says

December 12, 2023 Rich Daly, Editor in Chief Views

Maureen Testoni, president and CEO of 340B Health, said she anticipates bipartisan legislation on drugmaker 340B contract pharmacy restrictions.

Months after it was expected, bipartisan legislation to prevent drugmaker restrictions on the use of contract pharmacies by 340B providers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Missouri State Senator to Reintroduce 340B Contract Pharmacy, PBM Protection Bill

December 12, 2023 William Newton, Associate Editor/Senior Writer Views

The Missouri state senate recently passed a 340B contract pharmacy access bill.

A Missouri state senator has filed to reintroduce a bill that would bar drugmaker 340B contract pharmacy restrictions and pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Drugmakers Highlight 340B Developments in Earnings Calls

December 12, 2023 Rich Daly, Editor in Chief Views

Jean-Jacques Bienaime, CEO of drugmaker BioMarin, discussed the impact of 340B on pharmaceutical sales during an investor earnings call.

Pharmaceutical company executives discussed a range of 340B-related developments in recent third quarter investor calls. An executive for BioMarin Pharmaceutical, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Amid Record Drugmaker Refunds, No Adverse Audit Findings for Teva

December 7, 2023 Rich Daly, Editor in Chief Views

The final HRSA manufacturer 340B program audit conducted in fiscal year 2023 had no adverse findings for Teva Pharmaceuticals.

The fifth and final fiscal year 2023 manufacturer audit by federal officials recently concluded with no adverse findings. Meanwhile, the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Category: Pharma Industry

J&J Offers Refunds on Blockbuster Drug, Other Manufacturers Update NDCs

Please Login or Become a Paid Subscriber to View this Content

If you are already a

2023 Contract Pharmacy Developments: Surging Restrictions, State Law Legal Battles

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Louisiana, Health Centers Seek Dismissal of Contract Pharmacy Law Challenge

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

Lilly to Conduct HRSA-Approved Audit That Includes First-Time Look for Medicaid MCO Duplicate Discounts

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Takeda Becomes 29th Drugmaker to Implement 340B Contract Pharmacy Restrictions

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Novo Nordisk to Provide 340B Refunds on Hemophilia Drugs

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Legislation ‘Is Coming’ to Address Contract Pharmacy Restrictions, Hospital Advocate Says

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Missouri State Senator to Reintroduce 340B Contract Pharmacy, PBM Protection Bill

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Drugmakers Highlight 340B Developments in Earnings Calls

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Amid Record Drugmaker Refunds, No Adverse Audit Findings for Teva

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live